Medicare Enrolled

Dr. David Ng, MD

Pulmonary Disease · Beverly Hills, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
150 N ROBERTSON BLVD, Beverly Hills, CA 90211
3104245480
In practice since 2007 (19 years)
NPI: 1558484618 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ng from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ng? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ng

Dr. David Ng is a pulmonary disease specialist in Beverly Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ng performed 3,069 Medicare services across 1,624 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ng received a total of $10,157 from 52 pharmaceutical and/or device companies across 347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ng is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 11% volume in CA $10,157 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,069
Medicare services
Top 11% in CA for pulmonary disease
1,624
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~162 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
805 $103 $182
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
666 $100 $275
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
243 $34 $110
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
150 $8 $22
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
139 $49 $156
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
139 $52 $105
Lung volume measurement test
A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs.
127 $13 $31
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
91 $132 $247
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
87 $30 $64
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
86 $8 $15
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
71 $8 $11
Liver function blood test panel 70 $8 $15
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
68 $145 $300
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
54 $12 $43
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
45 $155 $293
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
34 $15 $25
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
31 $16 $25
Cardiac enzyme level (CK-MB) test
A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage.
28 $6 $10
Parathyroid hormone level test
A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones.
27 $40 $64
Folic acid level test
A blood test that measures the amount of folic acid in the serum.
26 $14 $26
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
25 $171 $331
Total cortisol level test
A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands.
20 $16 $24
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
20 $10 $26
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
17 $25 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
0.8% medium
97.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,157
Total received (2018-2024)
Avg $1,451/year across 7 years
Top 16% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
347
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,157 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,592
2023
$1,459
2022
$2,015
2021
$2,466
2020
$912
2019
$989
2018
$724

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$276
Boehringer Ingelheim Pharmaceuticals, Inc.
$200
Amgen Inc.
$199
Collegium Pharmaceutical, Inc.
$192
Kiniksa Pharmaceuticals International, plc
$72
Novo Nordisk Inc
$71
Grifols USA, LLC
$60
Lexicon Pharmaceuticals, Inc.
$58
Mylan Specialty L.P.
$50
Antares Pharma, Inc.
$43
Alnylam Pharmaceuticals Inc.
$42
Bayer Healthcare Pharmaceuticals Inc.
$36
AstraZeneca Pharmaceuticals LP
$36
Mallinckrodt Hospital Products Inc.
$34
Insmed, Inc.
$27
Edwards Lifesciences Corporation
$25
HEARTFLOW, INC.
$23
GlaxoSmithKline, LLC.
$22
Otsuka America Pharmaceutical, Inc.
$22
Lilly USA, LLC
$20
Baxter Healthcare
$18
E.R. Squibb & Sons, L.L.C.
$17
GENZYME CORPORATION
$17
Electromed, Inc.
$16
Azurity Pharmaceuticals, Inc.
$16
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$2,723
Amgen Inc.
$1,042
AstraZeneca Pharmaceuticals LP
$872
Boehringer Ingelheim Pharmaceuticals, Inc.
$755
Novartis Pharmaceuticals Corporation
$411
Mylan Specialty L.P.
$337
GlaxoSmithKline, LLC.
$298
PFIZER INC.
$257
Janssen Pharmaceuticals, Inc
$251
Pulmonx Corporation
$241
Collegium Pharmaceutical, Inc.
$192
Edwards Lifesciences Corporation
$180
Novo Nordisk Inc
$176
Intuitive Surgical, Inc.
$173
Otsuka America Pharmaceutical, Inc.
$161
Alnylam Pharmaceuticals Inc.
$161
DAVOL INC.
$158
E.R. Squibb & Sons, L.L.C.
$155
Grifols USA, LLC
$151
Electromed, Inc.
$137
Regeneron Healthcare Solutions, Inc.
$119
Lilly USA, LLC
$97
Mallinckrodt Hospital Products Inc.
$90
Advanced Respiratory, Inc
$83
Kiniksa Pharmaceuticals International, plc
$72
GENZYME CORPORATION
$70
Bayer Healthcare Pharmaceuticals Inc.
$69
Lexicon Pharmaceuticals, Inc.
$58
Shionogi Inc
$57
Bayer HealthCare Pharmaceuticals Inc.
$45
Genentech USA, Inc.
$43
Antares Pharma, Inc.
$43
Baxter Healthcare
$42
ARBOR PHARMACEUTICALS, INC.
$35
Merck Sharp & Dohme LLC
$33
IDORSIA PHARMACEUTICALS US INC
$33
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$31
Azurity Pharmaceuticals, Inc.
$31
Insmed, Inc.
$27
Mallinckrodt LLC
$27
Philips Electronics North America Corporation
$23
HEARTFLOW, INC.
$23
Actelion Pharmaceuticals US, Inc.
$21
Daiichi Sankyo Inc.
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$21
Boston Scientific Corporation
$21
Seqirus USA Inc
$19
Merck Sharp & Dohme Corporation
$17
HeartFlow, Inc.
$16
Arbor Pharmaceuticals, Inc.
$15
MEDICOMP INC
$13
Teva Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 45.7% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · ACTHAR · AIRSUPRA · AJOVY · AMVUTTRA · AREXVY · ARISTA AH · Arcalyst · Arikayce · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · Belbuca · CHARTIS CATHETER · CONFIRM RX · CardioMEMS HF System · Confirm Rx · DUPIXENT · Da Vinci Surgical System · Dymista · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Esbriet · FASENRA · FFRct · Fetroja · Fluad Quadrivalent · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Hillrom - Vest System Model 105 Home Care · INJECTAFER · JANUVIA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LEQVIO · LifeVest · MOUNJARO · NUCALA · OFEV · ONPATTRO · OPSUMIT · Otezla · Ozempic · PAXLOVID · PRALUENT · Parsabiv · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QUVIVIQ · Repatha · Rybelsus · SAMSCA · SAPIEN 3 Ultra RESILIA · SHINGRIX · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TAGRISSO · TELEPATCH CARDIAC MONITOR · TEZSPIRE · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · XTAMPZA · XYOSTED · Xofluza · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Beverly Hills?
Compare pulmonary diseases in the Beverly Hills area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
261
Per 100K population
2.7
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ng is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ng experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ng performed 805 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ng receive payments from pharmaceutical companies?
Yes. Dr. Ng received a total of $10,157 from 52 companies across 347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ng's costs compare to other pulmonary diseases in Beverly Hills?
Dr. Ng's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ng) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →